222 related articles for article (PubMed ID: 23572481)
1. Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.
Tan DH; Raboud JM; Kaul R; Brunetta J; Kaushic C; Kovacs C; Lee E; Luetkehoelter J; Rachlis A; Smaill F; Smieja M; Walmsley SL
Clin Infect Dis; 2013 Aug; 57(3):448-57. PubMed ID: 23572481
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
3. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies.
Tan DH; Murphy K; Shah P; Walmsley SL
BMC Infect Dis; 2013 Oct; 13():502. PubMed ID: 24164861
[TBL] [Abstract][Full Text] [Related]
5. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.
Stinn T; Kuntz S; Varon D; Huang ML; Selke S; Njikan S; Ford ES; Dragavon J; Coombs RW; Johnston C; Bull ME
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028713
[TBL] [Abstract][Full Text] [Related]
6. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection.
Cornelissen M; Pasternak AO; Grijsen ML; Zorgdrager F; Bakker M; Blom P; Prins JM; Jurriaans S; van der Kuyl AC
Clin Infect Dis; 2012 Feb; 54(4):539-47. PubMed ID: 22157174
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level.
Wright PW; Hoesley CJ; Squires KE; Croom-Rivers A; Weiss HL; Gnann JW
Clin Infect Dis; 2003 Jan; 36(2):207-11. PubMed ID: 12522754
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya.
Mugo N; Dadabhai SS; Bunnell R; Williamson J; Bennett E; Baya I; Akinyi N; Mohamed I; Kaiser R
Sex Transm Dis; 2011 Nov; 38(11):1059-66. PubMed ID: 21992985
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
11. Role of Interleukin 32 in Human Immunodeficiency Virus Reactivation and Its Link to Human Immunodeficiency Virus-Herpes Simplex Virus Coinfection.
Mesquita PMM; Preston-Hurlburt P; Keller MJ; Vudattu N; Espinoza L; Altrich M; Anastos K; Herold KC; Herold BC
J Infect Dis; 2017 Feb; 215(4):614-622. PubMed ID: 28007920
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.
Ameli N; Bacchetti P; Morrow RA; Hessol NA; Wilkin T; Young M; Cohen M; Minkoff H; Gange SJ; Greenblatt RM
AIDS; 2006 Apr; 20(7):1051-8. PubMed ID: 16603858
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
[TBL] [Abstract][Full Text] [Related]
14. Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in Lesotho.
Rabenau HF; Lennemann T; Kircher C; Gürtler L; Staszewski S; Preiser W; McPherson P; Allwinn R; Doerr HW
Sex Transm Dis; 2010 Jul; 37(7):454-9. PubMed ID: 20531031
[TBL] [Abstract][Full Text] [Related]
15. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
[TBL] [Abstract][Full Text] [Related]
16. Lack of association of herpes simplex virus type 2 seropositivity with the progression of HIV infection in the HERS cohort.
Hoots BE; Hudgens MG; Cole SR; King CC; Klein RS; Mayer KH; Rompalo AM; Sobel JD; Jamieson DJ; Smith JS
Am J Epidemiol; 2011 Apr; 173(7):837-44. PubMed ID: 21372062
[TBL] [Abstract][Full Text] [Related]
17. Chronic herpes simplex virus type-2 infection and HIV viral load.
Duffus WA; Mermin J; Bunnell R; Byers RH; Odongo G; Ekwaru P; Downing R
Int J STD AIDS; 2005 Nov; 16(11):733-5. PubMed ID: 16303067
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.
Baeten JM; McClelland RS; Corey L; Overbaugh J; Lavreys L; Richardson BA; Wald A; Mandaliya K; Bwayo JJ; Kreiss JK
J Infect Dis; 2004 Apr; 189(8):1466-71. PubMed ID: 15073684
[TBL] [Abstract][Full Text] [Related]
19. Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals.
Fife KH; Mugwanya K; Thomas KK; Baeten JM; Celum C; Bukusi E; de Bruyn G; Mujugira A; Vwalika B; Wald A; Lingappa JR;
J Infect Dis; 2016 May; 213(10):1573-8. PubMed ID: 26704611
[TBL] [Abstract][Full Text] [Related]
20. The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.
Van Wagoner N; Geisler WM; Bachmann LH; Hook EW
Int J STD AIDS; 2015 Jul; 26(8):574-81. PubMed ID: 25147236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
